Literature DB >> 19318028

Pregnancy associated plasma protein A, a potential marker for vulnerable plaque in patients with non-ST-segment elevation acute coronary syndrome.

Kasper K Iversen1, Ane S Teisner, Borge Teisner, Anette Kliem, Pia Thanning, Henrik Nielsen, Peter Clemmensen, Peer Grande.   

Abstract

OBJECTIVES: To describe the presence and time-related pattern of circulating pregnancy associated plasma protein A (PAPP-A) levels in patients with non ST-segment elevation acute coronary syndrome (NSTE-ACS). DESIGN AND METHODS: Consecutively admitted patients (N=573) with clinical signs of NSTE-ACS were included. Blood samples for analysis of PAPP-A were drawn at admission and every 6-8 h until levels of biomarkers of myocardial necrosis showed a consistent decrease.
RESULTS: High-risk NSTE-ACS was diagnosed in 123 patients (23%). Significantly more patients with high-risk NSTE-ACS (63%) had detectable PAPP-A than did those with low-risk NSTE-ACS (49%) (P<0.001). PAPP-A concentrations were significantly associated with typical angina at admission, significant ST-depressions on the ECG, multivessel disease and presence of high-risk NSTE-ACS.
CONCLUSION: PAPP-A seems to be a marker ischaemia both in patients with low- and high-risk NSTE-ACS, possibly due to the release of PAPP-A from the vulnerable plaque.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19318028     DOI: 10.1016/j.clinbiochem.2009.01.011

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  4 in total

1.  Value of serum pregnancy-associated plasma protein A for predicting cardiovascular events among patients presenting with cardiac chest pain.

Authors:  Stephan von Haehling; Wolfram Doehner; Ewa A Jankowska; Piotr Ponikowski; Konstantinos Stellos; Valentina O Puntmann; Eike Nagel; Stefan D Anker; Meinrad Gawaz; Boris Bigalke
Journal:  CMAJ       Date:  2013-03-18       Impact factor: 8.262

2.  Pregnancy-associated plasma protein-A (PAPP-A) as a possible biomarker in patients with coronary artery disease.

Authors:  H Gutiérrez-Leonard; E Martínez-Lara; A E Fierro-Macías; V M Mena-Burciaga; M D Ronquillo-Sánchez; E Floriano-Sánchez; N Cárdenas-Rodríguez
Journal:  Ir J Med Sci       Date:  2016-10-11       Impact factor: 1.568

3.  Pregnancy-associated plasma protein A as a predictor of all-cause mortality and cardiovascular events in patients with chronic kidney disease: a meta-analysis of prospective studies.

Authors:  Yuehua Li; Xv Meng; Chenghui Zhou; Xianliang Zhou
Journal:  Arch Med Sci       Date:  2019-12-31       Impact factor: 3.318

4.  Examination of serum pregnancy-associated plasma protein A clinical value in acute coronary syndrome prediction and monitoring.

Authors:  Rafał Nikodem Wlazeł; Jacek Rysz; Marek Paradowski
Journal:  Arch Med Sci       Date:  2013-02-21       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.